59 related articles for article (PubMed ID: 21459007)
1. In vitro evaluation of apoptosis with 99mTc-glucoheptonate.
Kocagozoglu G; Lambrecht FY; Gunduz C; Yucebaş M; Tabar EB; Ozgur A; Balci T
Appl Radiat Isot; 2011 Jul; 69(7):955-9. PubMed ID: 21459007
[TBL] [Abstract][Full Text] [Related]
2. High sensitivity of a computerized radioisotopic method to evaluate unilateral renal blood flow reduction by first pass analysis and static imaging with 99mTc-glucoheptonate.
Fommei E; Bellina CR; Carmellini M; Palla L; Palombo C; Ghione S
J Nucl Med Allied Sci; 1983; 27(4):303-8. PubMed ID: 6325610
[No Abstract] [Full Text] [Related]
3. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy.
Subbarayan M; Häfeli UO; Feyes DK; Unnithan J; Emancipator SN; Mukhtar H
J Nucl Med; 2003 Apr; 44(4):650-6. PubMed ID: 12679412
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of technetium-99m glucoheptonate and gallium-67 citrate thoracic imaging in detection of mediastinal and hilar involvement in primary lung cancer.
Taillefer R; Beauchamp G; Léveillé J
Clin Nucl Med; 1986 Jan; 11(1):15-9. PubMed ID: 3455906
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the labeling efficiency and stability of technetium-99m-labeled glucoheptonate.
Zbrzeznj DJ; Khan RA
Am J Hosp Pharm; 1981 Oct; 38(10):1499-502. PubMed ID: 7294045
[TBL] [Abstract][Full Text] [Related]
6. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
7. Technetium radiopharmaceuticals: chemical characterization and tissue distribution of Tc-glucoheptonate using Tc-99m and carrier Tc-99.
de Kieviet W
J Nucl Med; 1981 Aug; 22(8):703-9. PubMed ID: 7264760
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-glucoheptonate as a brain-scanning agent: critical comparison with pertechnetate.
Waxman AD; Tanacescu D; Siemsen JK; Wolfstein RS
J Nucl Med; 1976 May; 17(5):345-8. PubMed ID: 1262934
[TBL] [Abstract][Full Text] [Related]
9. Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine.
Ahlgren S; Andersson K; Tolmachev V
Nucl Med Biol; 2010 Jul; 37(5):539-46. PubMed ID: 20610158
[TBL] [Abstract][Full Text] [Related]
10. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
Kriehuber R; Kadenbach K; Schultz F; Weiss DG
Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging.
He Z; Hsieh WY; Kim YS; Liu S
Nucl Med Biol; 2006 Nov; 33(8):1045-53. PubMed ID: 17127179
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m glucoheptonate imaging in lung cancer and benign lung disease: concise communication.
Passamonte PM; Seger RM; Holmes RA; Hurst DJ
J Nucl Med; 1983 Nov; 24(11):997-1000. PubMed ID: 6313880
[TBL] [Abstract][Full Text] [Related]
13. Renal imaging: comparison of technetium Tc 99m glucoheptonate with conventional arteriography.
Klein FA; Texter JH; Zelenak J; Hietala SO
South Med J; 1981 Feb; 74(2):187-90. PubMed ID: 7466437
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage and technetium-99m glucoheptonate imaging in chronic eosinophilic pneumonia.
Lieske TR; Sunderrajan EV; Passamonte PM
Chest; 1984 Feb; 85(2):282-4. PubMed ID: 6692712
[TBL] [Abstract][Full Text] [Related]
15. Nephroptosis: the Tc-99m glucoheptonate scan as a diagnostic method.
Kumar R; Gupta R; Reddy SN; Malhotra A
Clin Nucl Med; 2000 Jun; 25(6):473. PubMed ID: 10836700
[TBL] [Abstract][Full Text] [Related]
16. Immediate and delayed TC-99M glucoheptonate brain images.
Boade WA
S D J Med; 1981 Jun; 34(6):19-20. PubMed ID: 6943675
[No Abstract] [Full Text] [Related]
17. Early and delayed Tc-99m glucoheptonate brain scintigraphy: are routine early images indicated?
Tanasescu DE; Wolfstein RS; Brachman MB; Waxman AD
J Nucl Med; 1979 Apr; 20(4):287-90. PubMed ID: 536804
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of intracranial space-occupying lesion with Tc99m-glucoheptonate brain single photon emission computed tomography in treatment-naïve patients.
Jaiswal S; Barai S; ; Gambhir S; Ora M; Mahapatra AK
J Postgrad Med; 2009; 55(3):180-4. PubMed ID: 19884742
[TBL] [Abstract][Full Text] [Related]
19. The value of obtaining renal images following brain scintigraphy with technetium-99m glucoheptonate.
Moreno AJ; Rodriguez AA; Spicer MJ; Jackson RE; Byrd BF; Turnbull GL
Clin Nucl Med; 1986 Aug; 11(8):560-3. PubMed ID: 3742911
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m glucoheptonate imaging. Retroperitoneal abscess.
Sty JR; Wells RG
Clin Nucl Med; 1990 Apr; 15(4):270-1. PubMed ID: 2340664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
